ArticleJournal of family medicine and primary care2025
Prevalence of hepatitis A virus (HAV) and hepatitis E virus (HEV) in patients presenting with acute viral hepatitis attending a teaching hospital in South India.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The hepatitis A virus (HAV) and hepatitis E virus (HEV) are transmitted enterically causing severe viral hepatitis in developing countries. Acute viral hepatitis (AVH) of variable severity in adults along with asymptomatic infection, typically in children, are the two main health issues caused by fecal-orally transmitted hepatitis in our nation. Objectives: This study aims to determine the prevalence, epidemiology, and biochemical correlation in AVH due to HAV and HEV. This study aims to study co-infection of HAV and HEV in AVH patients. Materials and Methods: Two years (January 2023-January 2025) of retrospective cross-sectional research were successfully executed in the Department of Microbiology at ESICMC and PGIMSR Rajajinagar, in Bangalore. In this research, 320 individuals who presented with AVH were taken into consideration. Commercially available enzyme-linked immunosorbent assay kits were used to analyze blood samples for immunoglobulin M (IgM) anti-HAV along with IgM anti-HEV to detect HAV and HEV, respectively, as per the history. Statistical Analysis: Demographic data along with clinical information had been gathered and examined, by using Statistical Package for the Social Sciences, version 26.0. Results: The incidence of HAV was 62.9%, HEV was 25.8%, whereas co-infection was 11.2%. Males had a greater incidence of HAV and HEV (85.7% and 56.5%, respectively) than females (14.3% and 43.5%, respectively). Children aged 0-14 years had a greater incidence of HAV infection, while adults had a greater prevalence of HEV. The highest levels were identified in co-infected subjects, and both HAV as well as HEV infections were linked to raised liver function indicators. Most instances occurred throughout June to October, that is in monsoon season. Conclusions: The prevalence of HAV is considerably greater compared to that of HEV, and an 11.2% co-infection rate necessitates HEV screening, which is crucial for enhancing personal hygiene. Minimizing the disease burden requires effective public health initiatives that address hygiene and sanitation, along with HAV vaccine campaigns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.